Neuphoria Therapeutics Inc (NEUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 15,650 | 0 | 0 | 191 | 0 |
| Gross Profit | 15,650 | N/A | N/A | 191 | N/A |
| Operating Expenses | 16,779 | 17,892 | 21,983 | 16,085 | 5,560 |
| Operating Income | -1,129 | -17,892 | -21,983 | -15,894 | -5,560 |
| Interest Expense | 0 | 0 | 0 | 32 | 1,079 |
| Other Income | 291 | 2,313 | 462 | 0 | 0 |
| Pre-tax Income | -838 | -15,580 | -21,521 | -15,926 | -6,639 |
| Income Tax | -468 | -87 | -139 | -139 | -140 |
| Net Income Continuous | -370 | -15,492 | -21,382 | -15,786 | -6,498 |
| Net Income | $-370 | $-15,492 | $-21,382 | $-15,786 | $-6,498 |
| EPS Basic Total Ops | -0.23 | -18.62 | -31.45 | -31.35 | -16.15 |
| EPS Basic Continuous Ops | -0.23 | -18.62 | -31.46 | -25.20 | -18.00 |
| EPS Diluted Total Ops | -0.23 | -18.62 | -31.45 | -31.35 | -16.15 |
| EPS Diluted Continuous Ops | -0.23 | -18.62 | -31.46 | -25.20 | -18.00 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -21.25 | -29.05 | -31.33 | N/A |
| EBITDA(a) | $-466 | $-17,229 | $-21,320 | $-15,089 | $-4,289 |